Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 2 |
2020 | 5 |
2021 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Serum soluble CD163 and proinflammatory chemokines may be biomarkers of the onset of adverse events in dabrafenib plus trametinib combination therapy for advanced melanoma.
Dermatol Ther. 2021 Jan;34(1):e14544. doi: 10.1111/dth.14544. Epub 2020 Nov 22.
Dermatol Ther. 2021.
PMID: 33190370
Erythema nodosum developed in a patient with advanced cutaneous melanoma treated with dabrafenib plus trametinib combination therapy.
Muto Y, Fujimura T, Kambayashi Y, Ohuchi K, Amagai R, Okuma T, Furudate S, Hashimoto A, Aiba S.
Muto Y, et al.
Dermatol Ther. 2020 Nov;33(6):e14430. doi: 10.1111/dth.14430. Epub 2020 Oct 26.
Dermatol Ther. 2020.
PMID: 33078860
No abstract available.
Item in Clipboard
Significance of Immunosuppressive Cells as a Target for Immunotherapies in Melanoma and Non-Melanoma Skin Cancers.
Fujimura T, Aiba S.
Fujimura T, et al.
Biomolecules. 2020 Jul 22;10(8):1087. doi: 10.3390/biom10081087.
Biomolecules. 2020.
PMID: 32707850
Free PMC article.
Review.
Item in Clipboard
Severe pyrexia from nivolumab-resistant advanced melanoma after successful combined therapy with encorafenib plus binimetinib.
Amagai R, Fujimura T, Kambayashi Y, Sato Y, Tanita K, Ohuchi K, Hashimoto A, Aiba S.
Amagai R, et al.
J Dermatol. 2020 Jun;47(6):654-657. doi: 10.1111/1346-8138.15346. Epub 2020 Apr 15.
J Dermatol. 2020.
PMID: 32293049
Item in Clipboard
Immune checkpoint inhibitor-induced vitiligo in advanced melanoma could be related to increased levels of CCL19.
Fujimura T, Tanita K, Sato Y, Lyu C, Kambayashi Y, Fujisawa Y, Uchi H, Yamamoto Y, Otsuka A, Yoshino K, Matsushita S, Funakoshi T, Fukushima S, Hata H, Hashimoto A, Aiba S.
Fujimura T, et al.
Br J Dermatol. 2020 May;182(5):1297-1300. doi: 10.1111/bjd.18721. Epub 2019 Dec 17.
Br J Dermatol. 2020.
PMID: 31746456
No abstract available.
Item in Clipboard
Significance of BRAF Kinase Inhibitors for Melanoma Treatment: From Bench to Bedside.
Fujimura T, Fujisawa Y, Kambayashi Y, Aiba S.
Fujimura T, et al.
Cancers (Basel). 2019 Sep 11;11(9):1342. doi: 10.3390/cancers11091342.
Cancers (Basel). 2019.
PMID: 31514399
Free PMC article.
Review.
Item in Clipboard
Cite
Cite